1. Home
  2. INZY vs ALCO Comparison

INZY vs ALCO Comparison

Compare INZY & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • ALCO
  • Stock Information
  • Founded
  • INZY 2015
  • ALCO 1960
  • Country
  • INZY United States
  • ALCO United States
  • Employees
  • INZY N/A
  • ALCO N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • INZY Health Care
  • ALCO
  • Exchange
  • INZY Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • INZY 188.2M
  • ALCO 186.1M
  • IPO Year
  • INZY 2020
  • ALCO N/A
  • Fundamental
  • Price
  • INZY $1.65
  • ALCO $29.78
  • Analyst Decision
  • INZY Strong Buy
  • ALCO
  • Analyst Count
  • INZY 7
  • ALCO 0
  • Target Price
  • INZY $16.43
  • ALCO N/A
  • AVG Volume (30 Days)
  • INZY 666.9K
  • ALCO 93.8K
  • Earning Date
  • INZY 11-05-2024
  • ALCO 02-05-2025
  • Dividend Yield
  • INZY N/A
  • ALCO 0.69%
  • EPS Growth
  • INZY N/A
  • ALCO 279.17
  • EPS
  • INZY N/A
  • ALCO 0.91
  • Revenue
  • INZY N/A
  • ALCO $46,643,000.00
  • Revenue This Year
  • INZY N/A
  • ALCO $91.35
  • Revenue Next Year
  • INZY N/A
  • ALCO N/A
  • P/E Ratio
  • INZY N/A
  • ALCO $31.77
  • Revenue Growth
  • INZY N/A
  • ALCO 17.06
  • 52 Week Low
  • INZY $1.97
  • ALCO $24.14
  • 52 Week High
  • INZY $7.80
  • ALCO $34.08
  • Technical
  • Relative Strength Index (RSI)
  • INZY 24.23
  • ALCO 61.40
  • Support Level
  • INZY $2.68
  • ALCO $25.59
  • Resistance Level
  • INZY $3.18
  • ALCO $34.08
  • Average True Range (ATR)
  • INZY 0.27
  • ALCO 1.19
  • MACD
  • INZY -0.08
  • ALCO 0.39
  • Stochastic Oscillator
  • INZY 0.35
  • ALCO 49.55

About INZY Inozyme Pharma Inc.

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: